Dld Asset Management, LP Axsome Therapeutics, Inc. Put Options Transaction History

Dld Asset Management, LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $1.28 Million - $2.48 Million	-35,500 Reduced 70.3%	15,000 $670,000
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $815,249 - $1.75 Million	37,500 Added 288.46%	50,500 $1.93 Million
Q4 2021 Feb 22, 2022	SELL	$30.7 - $43.36 $39.5 Million - $55.8 Million	-1,287,000 Reduced 99.0%	13,000 $491,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $39.9 Million - $56.4 Million	1,300,000 New	1,300,000 $491,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.